According to The Insight Partners’ research, the global Cardiovascular Needle Market accounted for US$ 84,429.33 thousand in 2021 and is estimated to reach US$ 137,855.25 thousand by 2028, registering a stellar annual growth rate of 7.3% from 2021 to 2028. Increasing prevalence of cardiovascular diseases (CVDs) and rising geriatric population are the potential factors attributed to the market expansion.

Cardiovascular diseases include cerebrovascular disease, coronary heart disease, rheumatic heart disease, and other conditions. Tobacco consumption, unhealthy diet, physical inactivity, hypertension, diabetes, and increased cholesterol levels are among the other risk factors leading to CVDs. According to the WHO, CVDs are the leading cause of death worldwide. Over 17.9 million people succumbed to CVDs in 2016, which was 31.0% of the total mortality cases reported that year. As per the European Cardiovascular Disease Statistics 2017, CVDs cause almost 3.9 million deaths in Europe every year. The Journal of American College of Cardiology stated that Asia has an increasingly high prevalence of high blood pressure, diabetes, and elevated cholesterol levels.

Older people are at high risk of cardiac diseases due to weak immunity and other health issues. The systolic blood pressure increases with aging and leads to the stiffening of heart muscles and blood vessels. People aged 75 and above commonly suffer from hypertension causing coronary artery disorder and heart failure. According to the United Nation’s World Population Ageing 2017 report, around 962 million people across the world were aged 60 and above, and the number is expected to reach close to 2.1 billion by 2050. As per the US Census Bureau, the number of Americans of age 65 and above is likely to reach over 98 million by 2060. The global geriatric population is anticipated to reach 1.4 billion, 2.1 billion, and over 3.1 billion by 2030, 2050, and 2100, respectively. Elderly population suffers from various structural and functional disorders in their cardiovascular system. Thus, the rising geriatric population coupled with CVDs drive the global cardiovascular needle market.

On the contrary, the preference for surgical staples over needles hampers the growth of global cardiovascular needle market.